Trial | NCT00425256  Report issue

Title

Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    None
This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
Study Started
Feb 28
2006
Primary Completion
May 31
2007
Study Completion
May 31
2007
Last Update
Feb 23
2011
Estimate

Drug Bremelanotide

Criteria 

Inclusion Criteria:

Post menopausal and in general good health
In a stable relationship with a male partner for at least 6 months
Willing to attempt sexual activity once a week with your partner
No Results Posted